This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

In January 2025, Wockhardt announced that ZAYNICH demonstrated unprecedented efficacy in a global, pivotal Phase III study ...

GSK has resubmitted its NDA to the FDA for tebipenem HBr, an oral carbapenem for complicated UTIs, backed by positive phase 3 trial results.

Artificial intelligence is revolutionizing antibiotic discovery, potentially tackling antibiotic-resistant bacteria and ...

FROM nausea to constipation, ‘Ozempic teeth’ to ‘Ozem-d*ck’, we’ve heard it all when it comes to fat jab side effects. But ...

Antibiotics once turned deadly infections into curable ones. That trust is now cracking. Across hospitals and homes, germs ...

Many women believe public toilets or tight pants cause UTIs, but that’s a myth. So what really leads to recurrent infections, and how can they be treated without antibiotics?

Antibiotics are often taken casually, but repeated misuse is quietly changing how the body reacts to infections, making ...

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...

A doctor at the Chambersburg Hospital was accused of fatally prescribing opioids to a 63-year-old woman with an opioid sensitivity.